These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 30733667)
21. Ultrastructural and immunohistochemical segregation of gemistocytic subsets. Kros JM; Stefanko SZ; de Jong AA; van Vroonhoven CC; van der Heul RO; van der Kwast TH Hum Pathol; 1991 Jan; 22(1):33-40. PubMed ID: 1985075 [TBL] [Abstract][Full Text] [Related]
22. Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy. Tanaka S; Luk S; Kiyokawa J; Onozato ML; Iafrate AJ; Shah K; Martuza RL; Rabkin SD; Batchelor TT; Cahill DP; Chi AS; Wakimoto H Sci Rep; 2019 Jan; 9(1):139. PubMed ID: 30644426 [TBL] [Abstract][Full Text] [Related]
23. Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. Balsas P; Esteve-Arenys A; Roldán J; Jiménez L; Rodríguez V; Valero JG; Chamorro-Jorganes A; de la Bellacasa RP; Teixidó J; Matas-Céspedes A; Moros A; Martínez A; Campo E; Sáez-Borderías A; Borrell JI; Pérez-Galán P; Colomer D; Roué G J Hematol Oncol; 2017 Mar; 10(1):80. PubMed ID: 28359287 [TBL] [Abstract][Full Text] [Related]
24. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841 [TBL] [Abstract][Full Text] [Related]
25. Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma. Tanaka H; Kaneko N; Sakagami H; Matsuya T; Hiramoto M; Yamanaka Y; Mori M; Koshio H; Hirano M; Takeuchi M Leuk Res; 2020 Jan; 88():106286. PubMed ID: 31865062 [TBL] [Abstract][Full Text] [Related]
26. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation. Morelli MB; Nabissi M; Amantini C; Farfariello V; Ricci-Vitiani L; di Martino S; Pallini R; Larocca LM; Caprodossi S; Santoni M; De Maria R; Santoni G Int J Cancer; 2012 Oct; 131(7):E1067-77. PubMed ID: 22492283 [TBL] [Abstract][Full Text] [Related]
27. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Feldkamp MM; Lala P; Lau N; Roncari L; Guha A Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712 [TBL] [Abstract][Full Text] [Related]
28. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future. Chen R; Cohen AL; Colman H Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978 [TBL] [Abstract][Full Text] [Related]
29. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
30. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108 [TBL] [Abstract][Full Text] [Related]
31. ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas. Fan X; Wang Y; Zhang C; Liu L; Yang S; Wang Y; Liu X; Qian Z; Fang S; Qiao H; Jiang T Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571068 [TBL] [Abstract][Full Text] [Related]
32. Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient. Larsson S; Wenger A; Dósa S; Sabel M; Kling T; Carén H Carcinogenesis; 2018 Oct; 39(10):1304-1309. PubMed ID: 29982329 [TBL] [Abstract][Full Text] [Related]
33. LAPTM4B-35 is a novel prognostic factor for glioblastoma. Dong X; Tamura K; Kobayashi D; Ando N; Sumita K; Maehara T J Neurooncol; 2017 Apr; 132(2):295-303. PubMed ID: 28097442 [TBL] [Abstract][Full Text] [Related]
34. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines. Reifenberger G; Bilzer T; Seitz RJ; Wechsler W Acta Neuropathol; 1989; 78(3):270-82. PubMed ID: 2475009 [TBL] [Abstract][Full Text] [Related]
35. Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma. Qazi MA; Vora P; Venugopal C; Adams J; Singh M; Hu A; Gorelik M; Subapanditha MK; Savage N; Yang J; Chokshi C; London M; Gont A; Bobrowski D; Grinshtein N; Brown KR; Murty NK; Nilvebrant J; Kaplan D; Moffat J; Sidhu S; Singh SK Cancer Res; 2018 Sep; 78(17):5023-5037. PubMed ID: 29945963 [TBL] [Abstract][Full Text] [Related]
36. Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines. Halatsch ME; Gehrke EE; Vougioukas VI; Bötefür IC; A-Borhani F; Efferth T; Gebhart E; Domhof S; Schmidt U; Buchfelder M J Neurosurg; 2004 Mar; 100(3):523-33. PubMed ID: 15035290 [TBL] [Abstract][Full Text] [Related]
37. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors]. Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091 [TBL] [Abstract][Full Text] [Related]
38. EGFR as a clinical marker in glioblastomas and other gliomas. Saadeh FS; Mahfouz R; Assi HI Int J Biol Markers; 2018 Jan; 33(1):22-32. PubMed ID: 28885661 [TBL] [Abstract][Full Text] [Related]